4//SEC Filing
See Tai Sandi 4
Accession 0002009350-25-000003
CIK 0001907108other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 7:29 PM ET
Size
9.0 KB
Accession
0002009350-25-000003
Insider Transaction Report
Form 4
See Tai Sandi
Chief Development Officer
Transactions
- Sale
Common Stock
2025-10-17$8.94/sh−3,844$34,346→ 65,906 total - Sale
Common Stock
2025-10-17$9.56/sh−44$421→ 65,862 total - Award
Common Stock
2025-10-15+10,890→ 69,750 total
Footnotes (4)
- [F1]Represents a sale to cover tax obligations on the release of Restricted Stock Units ("RSUs").
- [F2]This transaction was executed in multiple trades at prices ranging from $8.53 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $9.53 to $9.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]Includes 49,138 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
Related Parties
1- filerCIK 0002009350
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 7:29 PM ET
- Size
- 9.0 KB